Glaukos CFO Alex R. Thurman sells 15,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Glaukos Corp. SVP and Chief Financial Officer Alex R. Thurman exercised options for 15,000 common shares at a $45.71 exercise price on November 18, 2026, then sold 15,000 shares at reported weighted-average prices from $232.65 to $246.12 per share in 13 transactions. The option exercise and sales were made under a Rule 10b5-1 trading plan adopted August 18, 2026; the options expire March 15, 2027. The reported option position following the exercise was zero.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F16, F17 | 15,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 15,000 | $45.71 | $686K |
| Sale | Common Stock F2, F3, F1 | 3,209 | $232.65 | $747K |
| Sale | Common Stock F2, F4, F1 | 1,493 | $233.62 | $349K |
| Sale | Common Stock F2, F5, F1 | 2,330 | $234.78 | $547K |
| Sale | Common Stock F2, F6, F1 | 548 | $235.50 | $129K |
| Sale | Common Stock F2, F7, F1 | 2,021 | $237.43 | $480K |
| Sale | Common Stock F2, F8, F1 | 1,190 | $238.26 | $284K |
| Sale | Common Stock F2, F9, F1 | 826 | $239.52 | $198K |
| Sale | Common Stock F2, F10 | 1,123 | $240.24 | $270K |
| Sale | Common Stock F2, F11, F1 | 132 | $241.49 | $32K |
| Sale | Common Stock F2, F12, F1 | 368 | $242.67 | $89K |
| Sale | Common Stock F2, F13, F1 | 998 | $243.91 | $243K |
| Sale | Common Stock F2, F14, F1 | 494 | $244.40 | $121K |
| Sale | Common Stock F2, F15, F1 | 268 | $246.12 | $66K |
Footnotes (17)
- F1. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2026 with respect to options that expire on March 15, 2027.
- F3. This transaction was executed in multiple trades at prices ranging from $232.18 to $233.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $233.21 to $234.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $234.22 to $235.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $235.28 to $235.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $236.89 to $237.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $237.92 to $238.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $238.95 to $239.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F10. This transaction was executed in multiple trades at prices ranging from $239.96 to $240.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11. This transaction was executed in multiple trades at prices ranging from $241.00 to $241.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $242.01 to $243.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $243.28 to $244.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. This transaction was executed in multiple trades at prices ranging from $244.30 to $245.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. This transaction was executed in multiple trades at prices ranging from $245.51 to $246.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2026 with respect to options that expire on March 15, 2027.
- F17. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
restricted stock units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were the terms of Alex R. Thurman's GKOS option exercise?
Were Alex R. Thurman's GKOS sales made under a trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.